enVVeno Medical secures FDA IDE approval for venous valve study
enVVeno Medical has received the investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) for a…
29 Apr 2026
CareDx sharpens precision medicine focus with $260m Naveris acquisition
CareDx has agreed to acquire Naveris in a deal worth up to $260m, priming the company to inherit a blood‑based monitoring solution for viral‑mediated cancers. CareDx’s deal for the precision…
29 Apr 2026
Medtronic receives CE mark for Stealth surgical platform
Medtronic has received the CE mark for the Stealth AXiS surgical platform that combines planning, navigation, and robotics into a single integrated system. Approved for spine and cranial procedures, the…
29 Apr 2026
FDA approves Avatar Medical’s 3D image processing software
Avatar Medical’s software platform for processing CT and MR images into three-dimensional (3D) anatomical models has obtained US Food and Drug Administration (FDA) clearance. Known as Avatar Medical Vision, the…
29 Apr 2026
Abbott secures FDA approval for Ultreon 3.0 imaging platform
Abbott has received the US Food and Drug Administration (FDA) approval and CE Mark for its Ultreon 3.0 AI-powered coronary imaging platform. The approval enables the integration of automated imaging…
28 Apr 2026
Thermo Fisher agrees to sell microbiology business to Astorg in $1bn deal
Thermo Fisher has agreed to sell its microbiology business in a deal above $1bn to private equity firm Astorg, reflecting the life sciences giant’s ongoing pivot away from in vitro…
28 Apr 2026
Merck KGaA and Remepy join forces to develop combo drug-digital therapies
Merck KGaA has inked a collaboration deal with Israeli-US startup, Remepy, to explore the therapeutic potential of combination drug and app-based approaches in rare oncology – marking the first big…